80 likes | 91 Views
Market Overview:<br>According to our new research study on u201cGastroparesis Market Forecast to 2027 u2013 COVID-19 Impact and Analysis u2013 by Type, Drug Class Type, and Distribution Channel,u201d the market is expected to reach US$ 6,025.11 million by 2027 from US$ 4,338.61 million in 2019; it is estimated to grow at a CAGR of 4.3% from 2020 to 2027. The report highlights trends prevailing in the market, and the factors driving and hindering the market growth.Gastroparesis is a medical condition characterized by the disability of stomach to empty itself of food in the usual way. Damaged nerves such as vagus
E N D
Gastroparesis Market Global Analysis and Forecast to 2028 Email: sales@theinsightpartners.com
Email: sales@theinsightpartners.com Report Studies Gastroparesis Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Gastroparesis Type (Idiopathic, Diabetic, Post-Surgical, and Others), Drug Class Type (Prokinetic Agents, Botulinum Toxin Injections, and Antiemetic Agents), and Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Others) 2
Email: sales@theinsightpartners.com Gastroparesis Market Overview The gastroparesis market was valued at US$ 4,338.61 million in 2019 and is projected to reach US$ 6,025.11 millionby 2027; it is expected to grow at a CAGR of 4.3% from 2020 to 2027. On the basis of drug class type, the gastroparesis market is segmented into prokinetic agents, botulinum toxin injection, and antiemetic agents. In 2019, the prokinetic agents segment held the largest share of the market, and it is further estimated to register the highest CAGR of 4.7% during the forecast period. The growth of the market for this segment is attributed to the increasing preference for prokinetic agents for the treatment of gastroparesis. 3
Email: sales@theinsightpartners.com Key Segment Market Segment :- Gastroparesis Market – by Type Idiopathic ,Diabetic ,Post-surgical ,Others Gastroparesis Market – by Drug Class Type ,Prokinetic Agents ,Botulinum Toxin Injections ,Antiemetic Agents Gastroparesis Market – by Distribution Channel Hospital Pharmacies ,Retail Pharmacies ,Others 4
Email: sales@theinsightpartners.com $50,000 Gastroparesis Market Value $40,000 $30,000 CAGR of 4.3% $20,000 (2020-2027) $10,000 $0 20XX 20XX 20XX 20XX 20XX Download Sample 5
Email: sales@theinsightpartners.com Company Profiles EVOKE PHARMA Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.) Johnson and Johnson Services, Inc. Allergan Plc NEUROGASTRX, INC. TEVA PHARMACEUTICAL INDUSTRIES LTD Pfizer Inc. ANI Pharmaceuticals, Inc. Ipca Laboratories Ltd. Cinrx Pharma, LLC (Cindome Pharma) 6 Download Sample Here
Email: sales@theinsightpartners.com By Geography North America (the US, Canada, and Mexico) Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe) Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific) Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa) South & Central America (Brazil, Argentina, and the Rest of South & Central America). 7
THANK YOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com